Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

(OP:NYMXF)

0.0514 -0.0006 (-1.15%)
Streaming Delayed Price Updated: 3:42 PM EST, Dec 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about NYMXF

News headline image
Nymox Announces Dismissal of Delaware Action Against Ascella
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX Announces Trading Resumed and New Listing on OTCQB Market
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces Filing of Annual Report
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Annual Report
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Required to Resubmit Application to DKMA
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports Victory in Bahamas Litigation Against Terminated Ex-Employees – Court Awards Costs and Damages
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox December 27 Message to Shareholders
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports California Court Issues Preliminary Injunction Against Defendants Lanham, Riley, Cutler and Others
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
$250 Million Lawsuit Filed Against AscellaHealth by Nymox Accepted and Summons Issued in California Court
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Pharmaceutical Corporation Sues AscellaHealth For $250 Million
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX REPORTS: Bahamian Court Today Suspends Order of October 3, 2023 Rendering Riley-Lanham and Accomplices Planned Vote Unauthorized
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
NYMOX REPORTS NOTICE: California Court Issued A Temporary Restraining Order Enjoining Lanham, Riley, Cutler And Their Nevada Company After Court Hearing In Santa Ana, California, November 2, 2023
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
IMPORTANT MESSAGE TO NYMOX SHAREHOLDERS: NYMOX Cautions Against Unauthorized Improper Shareholder Meeting and Unauthorized Unregistered Solicitations
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
IMPORTANT NOTICE: NYMOX Cautions Shareholders Not to Take Calls or Participate in Unauthorized Improper Shareholder Meeting
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Notice: Nymox Informs Its Shareholders Not to Take Calls or Participate in An Unauthorized and Improper Shareholder Meeting
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports New NYMOZARFEX Marketing Application is Accepted For Review
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces Submission of New Marketing Authorization Application Submission for NYMOZARFEX (TM) for BPH
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Reports Completion of $2 Million Private Placement
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox Announces $2 Million Private Placement
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
News headline image
Nymox's 3-month ex-CFO was Awarded an Unauthorized and Undisclosed Treasury Directive for 100,000 Shares of Nymox Stock Without the Knowledge or Approval of the Nymox Board or Nymox’s CEO
Ex-CFO Provided to Nymox Before Appointment as CFO a Personal Resume with False Claim of Securing USD 62.5 million at his Previous Company 
From Nymox Pharmaceutical Corporation
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.